We found that CD24, PZP, COL1A1, COL1A2, LUM, VCAN, THBS2 and EPHA3 were potential biomarkers for distinguishing NAFLD/NASH. This evidence concerns the gene THBS2 and metabolic dysfunction-associated steatotic liver disease.